Literature DB >> 11469708

Electrogastrography: physiological basis and clinical application in diabetic gastropathy.

K L Koch1.   

Abstract

Electrogastrography is the recording and measurement of gastric myoelectrical activity from electrodes placed on the surface of the epigastrium. Normal electrogastrograms (EGGs) reflect 3 cycles per min (cpm) gastric myoelectrical activity produced by specialized pacemaker cells, the interstitial cells of Cajal, located in the muscular wall of the gastric corpus and antrum. Gastric dysrhythmias (tachygastrias and bradygastrias) are disturbances of the normal gastric pacesetter potentials and are associated with symptoms of nausea, epigastric fullness, and bloating and with hyperglycemia and delayed gastric emptying. In diabetic gastropathy, the normal 3-cpm electrical rhythm is replaced with bradygastrias, tachygastrias, and mixed or nonspecific dysrhythmias. Diagnosis of gastric dysrhythmias identifies an objective neuromuscular abnormality in diabetic patients with upper gastrointestinal (GI) symptoms. Correction of gastric dysrhythmias decreases upper GI symptoms and may improve gastric emptying all of which may enhance glucose control. The EGG diagnosis of gastric dysrhythmias provides new insights into gastric neuromuscular abnormalities and guides therapies to improve upper GI symptoms in patients with diabetes mellitus.

Entities:  

Mesh:

Year:  2001        PMID: 11469708     DOI: 10.1089/152091501750220019

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  23 in total

1.  Movement based artifacts may contaminate extracellular electrical recordings from GI muscles.

Authors:  O Bayguinov; G W Hennig; K M Sanders
Journal:  Neurogastroenterol Motil       Date:  2011-09-25       Impact factor: 3.598

2.  Analysis of pacemaker activity in the human stomach.

Authors:  Poong-Lyul Rhee; Ji Yeon Lee; Hee Jung Son; Jae J Kim; Jong Chul Rhee; Sung Kim; Sang Don Koh; Sung Jin Hwang; Kenton M Sanders; Sean M Ward
Journal:  J Physiol       Date:  2011-10-17       Impact factor: 5.182

3.  Gastric electrical activity and cardiovascular risk factors in relation to autonomic nervous function, hormonal responses, and health-related lifestyles in young men.

Authors:  Mutsuhiro Nakao; Mariko Nishikitani; Kyoko Nomura; Kanae Karita; Eiji Yano
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 4.  Histologic changes in diabetic gastroparesis.

Authors:  Gianrico Farrugia
Journal:  Gastroenterol Clin North Am       Date:  2014-12-19       Impact factor: 3.806

Review 5.  Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists.

Authors:  Paul Kuo; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy.

Authors:  Atsuya Suzuki; M Asahina; C Ishikawa; K M Asahina; K Honma; T Fukutake; T Hattori
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

7.  Osteopathic Manipulative Treatment Alters Gastric Myoelectric Activity in Healthy Subjects.

Authors:  Edward Shadiack; Noah Jouett; Amber van den Raadt; Roselle Liganor; Jacob Watters; Kendi Hensel; Michael Smith
Journal:  J Altern Complement Med       Date:  2018-10-30       Impact factor: 2.579

8.  Pacemaker phase shift in the absence of neural activity in guinea-pig stomach: a microelectrode array study.

Authors:  Shinsuke Nakayama; Ken Shimono; Hong-Nian Liu; Hideyasu Jiko; Noburu Katayama; Tadao Tomita; Kazunori Goto
Journal:  J Physiol       Date:  2006-09-21       Impact factor: 5.182

9.  Electrogastrography: poor correlation with antro-duodenal manometry and doubtful clinical usefulness in adults.

Authors:  Shahab Abid; Greger Lindberg
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

Review 10.  Diabetic gastroparesis: diagnosis and management.

Authors:  Jing Ma; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.